Use of Anti-phosphohistone H3 Immunohistochemistry to Determine Mitotic Rate in Thin Melanoma

American Journal of Dermatopathology - Tập 32 Số 7 - Trang 650-654 - 2010
David J Casper1, Kate I Ross2, Jane L. Messina1, Vernon K. Sondak3, Cheryl N Bodden1, Tim W McCardle3, L. Frank Glass3,1
1Department of Dermatology, University of South Florida, College of Medicine, Tampa, FL
2Department of Internal Medicine, Florida State University, College of Medicine, Tallahassee, FL
3Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Azzola, 2003, Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center., Cancer, 97, 1488, 10.1002/cncr.11196

Barnhill, 2005, The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma., J Cutan Pathol, 32, 268, 10.1111/j.0303-6987.2005.00310.x

Francken, 2004, The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up., Ann Surg Oncol, 11, 426, 10.1245/ASO.2004.07.014

Attis, 2007, Mitotic rate in melanoma: a reexamination., Am J Clin Pathol, 127, 380, 10.1309/LB7RTC61B7LC6HJ6

McGovern, 1986, The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification., Pathology, 18, 12, 10.3109/00313028609090822

Scolyer, 2003, Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas., Am J Surg Pathol, 27, 1571, 10.1097/00000478-200312000-00011

Brochez, 2002, Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions., J Pathol, 196, 459, 10.1002/path.1061

Colloby, 1991, Observer variation in the measurement of Breslow depth and Clarks level in thin cutaneous malignant melanoma., J Pathol, 163, 245, 10.1002/path.1711630310

Corona, 1996, Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions., J Clin Oncol, 14, 1218, 10.1200/JCO.1996.14.4.1218

Murali, 2009, Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma., Ann Surg, 249, 641, 10.1097/SLA.0b013e31819ed973

Colman, 2006, Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas., Am J Surg Pathol, 30, 657, 10.1097/01.pas.0000202048.28203.25

Ribalta, 2004, The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria., Am J Surg Pathol, 28, 1532, 10.1097/01.pas.0000141389.06925.d5

Nasr, 2008, Comparison of pHH3, Ki-67, and surviving immunoreactivity in benign and malignant melanocytic lesions., Am J Dermatopathol, 30, 117, 10.1097/DAD.0b013e3181624054

Paek, 2007, The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma., Cancer, 109, 100, 10.1002/cncr.22382

Kesmodel, 2005, Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas., Ann Surg Oncol, 12, 449, 10.1245/ASO.2005.04.027

Sondak, 2004, Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model., Ann Surg Oncol, 11, 247, 10.1245/ASO.2004.03.044

Schmoeckel, 1978, Prognostic index in malignant melanoma., Arch Dermatol, 114, 871, 10.1001/archderm.1978.01640180005001

Balch, 2009, Final version of 2009 AJCC melanoma staging and classification., J Clin Oncol, 27, 6199, 10.1200/JCO.2009.23.4799

Tapia, 2006, Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity., Am J Surg Pathol, 30, 83, 10.1097/01.pas.0000183572.94140.43

Veras, 2009, Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study., Int J Gynecol Pathol, 28, 316, 10.1097/PGP.0b013e318193df97

Hirata, 2004, Characterization of a monoclonal antibody, HTA28, recognizing a histone H3 phosphorylation site as a useful marker of M-phase cells., J Histochem Cytochem, 52, 1503, 10.1369/jhc.4A6285.2004

Ajiro, 1985, Specific site of histone H3 phosphorylation related to the maintenance of premature chromosome condensation. Evidence for catalytically induced interchange of the subunits., J Biol Chem, 260, 15379, 10.1016/S0021-9258(17)36260-9

Goto, 1999, Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation., J Biol Chem, 274, 25543, 10.1074/jbc.274.36.25543

Hendzel, 1997, Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation., Chromosoma, 106, 348, 10.1007/s004120050256

Li, 2005, Dynamic distribution of Ser-10 phosphorylated histone H3 in cytoplasm of MCF-7 and CHO cells during mitosis., Cell Res, 15, 120, 10.1038/sj.cr.7290276

Shibata, 1990, Mitosis-specific histone H3 phosphorylation in vitro in nucleosome structures., Eur J Biochem, 192, 87, 10.1111/j.1432-1033.1990.tb19199.x